期刊文献+

Liver transplantation following two conversions in a patient with huge hepatocellular carcinoma and portal vein invasion:A case report

下载PDF
导出
摘要 BACKGROUND Surgical resection and liver transplantation(LT)are the most effective curative options for hepatocellular carcinoma(HCC).However,few patients with huge HCC(>10 cm in diameter),especially those with portal vein tumor thrombus(PVTT),can receive these treatments.Selective internal radiation therapy(SIRT)can be used as a conversion therapy for them because it has the dual benefit of shrinking tumors and increasing residual hepatic volume.However,in patients with huge HCC,high lung absorbed dose often prevents them from receiving SIRT.CASE SUMMARY A 35-year-old man was admitted because of emaciation and pain in the hepatic region for about 1 month.The computed tomography scan showed a 20.2 cm×19.8 cm tumor located in the right lobe–left medial lobes with right portal vein and right hepatic vein invasion.After the pathological type of HCC was confirmed by biopsy,two conversions were presented.The first one was drug-eluting bead transarterial chemoembolization plus hepatic arterial infusion chemotherapy and lenvatinib and sintilimab,converted to SIRT,and the second one was sequential SIRT with continued systemic treatment.The tumor size significantly decreased from 20.2 cm×19.8 cm to 16.2 cm×13.8 cm,then sequentially to 7.8 cm×6.8 cm.In the meantime,the ratio of spared volume to total liver volume increased gradually from 34.4%to 55.7%,then to 62.9%.Furthermore,there was visualization of the portal vein,indicating regression of the tumor thrombus.Finally,owing to the new tumor in the left lateral lobe,the patient underwent LT instead of resection without major complications.CONCLUSION Patients with inoperable huge HCC with PVTT could be converted to SIRT first and accept surgery sequentially.
出处 《World Journal of Gastroenterology》 SCIE CAS 2024年第36期4071-4077,共7页 世界胃肠病学杂志(英文版)
  • 相关文献

参考文献2

二级参考文献22

  • 1Cheng Zhou,Yuanfei Peng,Kaiqian Zhou,Lan Zhang,Xiangyu Zhang,Lei Yu,Jie Hu,Feiyu Chen,Shuangjian Qiu,Jian Zhou,Jia Fan,Zhenggang Ren,Zheng Wang.Surgical resection plus radiofrequency ablation for the treatment of multifocal hepatocellular carcinoma[J].Hepatobiliary Surgery and Nutrition,2019,8(1):19-28. 被引量:27
  • 2Tianfu Wen,Chen Jin,Antonio Facciorusso,Matteo Donadon,Ho-Seong Han,Yilei Mao,Chaoliu Dai,Shuqun Cheng,Bixiang Zhang,Baogang Peng,Shunda Du,Changjun Jia,Feng Xu,Jie Shi,Juxian Sun,Peng Zhu,Satoshi Nara,JMichael Millis,Qiu Li,Weixia Chen,Wusheng Lu,Hong Tang,Lvnan Yan,Yong Zeng,Bo Li,Jiayin Yang,Wentao Wang,Hong Wu,Mingqing Xu,Zheyu Chen,Changli Lu,Chuan Li,Wei Peng,Xiaoyun Zhang.Multidisciplinary management of recurrent and metastatic hepatocellular carcinoma after resection: an international expert consensus[J].Hepatobiliary Surgery and Nutrition,2018,7(5):353-371. 被引量:45
  • 3Daniele Nicolini,Gianluca Svegliati-Baroni,Roberto Candelari,Cinzia Mincarelli,Alessandra Mandolesi,Italo Bearzi,Federico Mocchegiani,Andrea Vecchi,Roberto Montalti,Antonio Benedetti,Andrea Risaliti,Marco Vivarelli.Doxorubicin-eluting bead vs conventional transcatheter arterial chemoembolization for hepatocellular carcinoma before liver transplantation[J].World Journal of Gastroenterology,2013,19(34):5622-5632. 被引量:12
  • 4陈敏山,李锦清,梁惠宏,林小军,郭荣平,郑云,张亚奇.经皮射频消融与手术切除治疗小肝癌的疗效比较[J].中华医学杂志,2005,85(2):80-83. 被引量:144
  • 5Louise Barbier,David Fuks,Patrick Pessaux,Fabrice Muscari,Yves-Patrice Treut,Sandrine Faivre,Jacques Belghiti.Safety of Liver Resection for Hepatocellular Carcinoma After Sorafenib Therapy: A Multicenter Case-Matched Study[J].Annals of Surgical Oncology.2013(11) 被引量:2
  • 6Alessandro Cucchetti,Fabio Piscaglia,Matteo Cescon,Antonio Colecchia,Giorgio Ercolani,Luigi Bolondi,Antonio D. Pinna.Cost-effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinoma<!-- Doctopic: CAN -->[J].Journal of Hepatology.2013(2) 被引量:3
  • 7Tiffany Wong,Chung Lo.Resection Strategies for Hepatocellular Carcinoma[J].Semin Liver Dis.2013(03) 被引量:3
  • 8Jean–Charles Nault,Aurélien De Reyniès,Augusto Villanueva,Julien Calderaro,Sandra Rebouissou,Gabrielle Couchy,Thomas Decaens,Dominique Franco,Sandrine Imbeaud,Francis Rousseau,Daniel Azoulay,Jean Saric,Jean–Frédéric Blanc,Charles Balabaud,Paulette Bioulac–Sage,Alexis Laurent,Pierre Laurent–Puig,Josep M. Llovet,Jessica Zucman–Rossi.A Hepatocellular Carcinoma 5-Gene Score Associated With Survival of Patients After Liver Resection[J].Gastroenterology.2013(1) 被引量:3
  • 9Rita Golfieri,Josè Ignacio Bilbao,Livio Carpanese,Roberto Cianni,Daniele Gasparini,Samer Ezziddin,Philipp Marius Paprottka,Francesco Fiore,Alberta Cappelli,Macarena Rodriguez,Giuseppe Maria Ettorre,Adelchi Saltarelli,Onelio Geatti,Hojjat Ahmadzadehfar,Alexander R. Haug,Francesco Izzo,Emanuela Giampalma,Bruno Sangro,Giuseppe Pizzi,Ermanno Notarianni,Alessandro Vit,Kai Wilhelm,Tobias F. Jakobs,Secondo Lastoria.Comparison of the survival and tolerability of radioembolization in elderly vs. younger patients with unresectable hepatocellular carcinoma<!-- Doctopic: CAN -->[J].Journal of Hepatology.2013 被引量:2
  • 10Kiyoshi Hasegawa,Norihiro Kokudo,Masatoshi Makuuchi,Namiki Izumi,Takafumi Ichida,Masatoshi Kudo,Yonson Ku,Michiie Sakamoto,Osamu Nakashima,Osamu Matsui,Yutaka Matsuyama.Corrigendum to: “Comparison of resection and ablation for hepatocellular carcinoma: A cohort study based on a Japanese nationwide survey” [J Hepatol 2013;58:724–729][J].Journal of Hepatology.2013 被引量:2

共引文献131

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部